Pere Llorens
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Pere Llorens has a total of 278 co-authors. Here are the top co-authors by number of shared publications:
- Òscar Miró
Emergency Department, Hospital Clínic, IDIBAPS, University of Barcelona , Barcelona, Catalonia
17 shared publications Òscar Miró
15 shared publicationsJavier Jacob
Emergency Department, Hospital Universitari de Bellvitge, L’Hospitalet de Llobregat, Barcelona, Spain
13 shared publications- Javier Jacob
Emergency Department, Hospital Universitari de Bellvitge, Barcelona, Spain
12 shared publications Pablo Herrero
Emergency Department, Hospital Universitario Central de Asturias, Oviedo, Spain
11 shared publications- Francisco Javier Martín-Sánchez
Hospital Clinico San Carlos
10 shared publications
Latest Publications
- 29 September 2026
- Published by Elsevier in Medicina Clinica
- Vol. 166 (12)
La contención en el paciente mayor: más que una medida de seguridad, un marcador centinela de vulnerabilidad sistémica
- 29 September 2026
- Published by Elsevier in Medicina Clinica
- Vol. 166 (12)
La contención en el paciente mayor: más que una medida de seguridad, un marcador centinela de vulnerabilidad sistémica
- Open Access
- 18 September 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (9) , 1362
Fibroblast Growth Factor 23 and Outcomes in Acute Heart Failure
Worsening heart failure (WHF) is a complex clinical syndrome associated with a high risk of mortality and further decompensations, characterized by fluid overload and upregulated inflammatory and fibrotic processes linked to organ dysfunction. Fibroblast growth factor 23 (FGF23) is an emerging proxy of fibrosis and may interact to influence long-term outcomes in WHF patients. This study evaluated the association between FGF23 levels and long-term outcomes in patients with WHF evaluated in the emergency department (ED). A total of 635 patients from the EAHFE registry, enrolled during 2007, 2009, and 2011, were prospectively included. FGF23 was measured in the first blood sample obtained at ED presentation. During a median follow-up of 380 days (interquartile range: 126 to 456), all-cause mortality occurred in 216 patients (34.0%), while 351 patients (55.3%) experienced the composite endpoint of death/WHF ED reconsultation and 295 (46.5%) experienced death/HF hospitalization. Event rates increased progressively across FGF23 levels. Patients with FGF23 above the median (48.4 pg/mL) displayed higher rates (per 100 patient-years) of all-cause mortality (49 vs. 31, p = 0.003), death/WHF ED reconsultation (93 vs. 65, p = 0.003), and death/HF hospitalization (77 vs. 56, p = 0.043). In continuous analyses, each doubling of FGF23 remained significantly associated with an increased risk of all three outcomes after multivariable adjustment. These associations were consistent across clinically relevant subgroups, including those defined by age, sex, and kidney function, supporting the potential prognostic value of FGF23 within this cohort, although external validation is warranted.
- 18 September 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (9) , 1362
Open AccessFibroblast Growth Factor 23 and Outcomes in Acute Heart Failure
Worsening heart failure (WHF) is a complex clinical syndrome associated with a high risk of mortality and further decompensations, characterized by fluid overload and upregulated inflammatory and fibrotic processes linked to organ dysfunction. Fibroblast growth factor 23 (FGF23) is an emerging proxy of fibrosis and may interact to influence long-term outcomes in WHF patients. This study evaluated the association between FGF23 levels and long-term outcomes in patients with WHF evaluated in the emergency department (ED). A total of 635 patients from the EAHFE registry, enrolled during 2007, 2009, and 2011, were prospectively included. FGF23 was measured in the first blood sample obtained at ED presentation. During a median follow-up of 380 days (interquartile range: 126 to 456), all-cause mortality occurred in 216 patients (34.0%), while 351 patients (55.3%) experienced the composite endpoint of death/WHF ED reconsultation and 295 (46.5%) experienced death/HF hospitalization. Event rates increased progressively across FGF23 levels. Patients with FGF23 above the median (48.4 pg/mL) displayed higher rates (per 100 patient-years) of all-cause mortality (49 vs. 31, p = 0.003), death/WHF ED reconsultation (93 vs. 65, p = 0.003), and death/HF hospitalization (77 vs. 56, p = 0.043). In continuous analyses, each doubling of FGF23 remained significantly associated with an increased risk of all three outcomes after multivariable adjustment. These associations were consistent across clinically relevant subgroups, including those defined by age, sex, and kidney function, supporting the potential prognostic value of FGF23 within this cohort, although external validation is warranted.
- Open Access
- 8 September 2026
- Published by Springer Nature in Research Square
Safety, quality of life, and efficiency of hospital at home admission compared with conventional hospitalization in acute heart failure A systematic review and meta-analysis
Background: Acute heart failure (AHF) accounts for a major proportion of emergency department (ED) admissions, contributing to severe hospital crowding. Hospital-at-home (HAH) direct from the ED ("admission avoidance") has emerged as an alternative to conventional hospitalization (CH). We performed a systematic review and meta-analysis to evaluate the safety, clinical efficacy, and cost-efficiency of direct ED-to-HAH management in AHF. Methods: Following PRISMA and MOOSE guidelines, we searched PubMed, Web of Science, Cochrane, and Scopus for longitudinal studies (RCTs and observational cohorts) published up to December 31, 2025. Eligible studies compared direct HAH (admission avoidance (≥ 48h) versus CH in adult AHF patients presenting to the ED. Primary endpoint was long-term all-cause mortality. Secondary endpoints included index episode outcomes (in-hospital mortality, length of stay [LoS], care escalation) and 30-day post-discharge outcomes (rehospitalization, direct costs). Random-effects models were used to pool Odds Ratios (OR) and Standardized Mean Differences (SMD) with 95% confidence intervals (CI). Results: Eight studies (3 RCTs, 5 observational cohorts) comprising 3,107 patients (HAH: 817; CH: 2,290) were included. Regarding safety, no differences were found in in-hospital mortality (OR: 0.66; 95% CI: 0.24–1.80) or long-term mortality (7 studies: OR: 0.94; 95% CI: 0.70–1.26; I^2 = 0%; 3 RCTs: OR: 0.90; 95% CI: 0.38–2.13). Care escalation (HAH transfer to CH) occurred in 10.2% of cases (95% CI: 5.7–15.6%). Post-discharge efficacy favored HAH, showing a 40% reduction in 30-day all-cause rehospitalization (OR: 0.60; 95% CI: 0.44–0.82). Although LoS was longer in HAH (SMD: 0.42; 95% CI: 0.18–0.66), index episode costs were significantly lower (SMD: -2.42; 95% CI: -4.11 to -0.74), yielding an average saving of €2,214 per episode. Conclusions: Direct HAH admission from the ED for selected AHF patients is safe, clinically equivalent in mortality, and highly cost-effective, significantly reducing 30-day readmissions. HAH serves as a crucial ED decompression strategy for acute care networks.
- 8 September 2026
- Published by Springer Nature in Research Square
Open AccessSafety, quality of life, and efficiency of hospital at home admission compared with conventional hospitalization in acute heart failure A systematic review and meta-analysis
Background: Acute heart failure (AHF) accounts for a major proportion of emergency department (ED) admissions, contributing to severe hospital crowding. Hospital-at-home (HAH) direct from the ED ("admission avoidance") has emerged as an alternative to conventional hospitalization (CH). We performed a systematic review and meta-analysis to evaluate the safety, clinical efficacy, and cost-efficiency of direct ED-to-HAH management in AHF. Methods: Following PRISMA and MOOSE guidelines, we searched PubMed, Web of Science, Cochrane, and Scopus for longitudinal studies (RCTs and observational cohorts) published up to December 31, 2025. Eligible studies compared direct HAH (admission avoidance (≥ 48h) versus CH in adult AHF patients presenting to the ED. Primary endpoint was long-term all-cause mortality. Secondary endpoints included index episode outcomes (in-hospital mortality, length of stay [LoS], care escalation) and 30-day post-discharge outcomes (rehospitalization, direct costs). Random-effects models were used to pool Odds Ratios (OR) and Standardized Mean Differences (SMD) with 95% confidence intervals (CI). Results: Eight studies (3 RCTs, 5 observational cohorts) comprising 3,107 patients (HAH: 817; CH: 2,290) were included. Regarding safety, no differences were found in in-hospital mortality (OR: 0.66; 95% CI: 0.24–1.80) or long-term mortality (7 studies: OR: 0.94; 95% CI: 0.70–1.26; I^2 = 0%; 3 RCTs: OR: 0.90; 95% CI: 0.38–2.13). Care escalation (HAH transfer to CH) occurred in 10.2% of cases (95% CI: 5.7–15.6%). Post-discharge efficacy favored HAH, showing a 40% reduction in 30-day all-cause rehospitalization (OR: 0.60; 95% CI: 0.44–0.82). Although LoS was longer in HAH (SMD: 0.42; 95% CI: 0.18–0.66), index episode costs were significantly lower (SMD: -2.42; 95% CI: -4.11 to -0.74), yielding an average saving of €2,214 per episode. Conclusions: Direct HAH admission from the ED for selected AHF patients is safe, clinically equivalent in mortality, and highly cost-effective, significantly reducing 30-day readmissions. HAH serves as a crucial ED decompression strategy for acute care networks.
- 3 June 2026
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 108, 287-289
Corrigendum to “Prevalence, risk factors, and prognosis of the need for physical and chemical restraint in older patients attending emergency departments. EDEN-50” [American Journal of Emergency Medicine 105C (2026) 79–87].
- 3 June 2026
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 108, 287-289
Corrigendum to “Prevalence, risk factors, and prognosis of the need for physical and chemical restraint in older patients attending emergency departments. EDEN-50” [American Journal of Emergency Medicine 105C (2026) 79–87].
- 18 March 2026
- Published by BMJ in Emergency Medicine Journal
Fall risk prediction in older adults at the emergency department: where the guidelines do not fit
Background: Falls represent 10% of emergency department (ED) visits in older patients. Identification of those at risk for future falls is important to allow for preventive interventions. The aim of the study was to investigate the accuracy of a new algorithm, based on an adaptation of the World Falls Guidelines (WFG) for falls prevention and management, to identify patients at high risk of recurrent falls in a cohort of older patients with fall-related visits to the ED. Methods: The FALL-ER registry is a prospective, observational, multipurpose cohort including consecutive, community-dwelling patients age ≥65 years, attending the ED of five Spanish hospitals after a fall during 52 randomly selected days between 2014 and 2015. Variables necessary to operationalise the algorithm or a proxy when necessary were recorded. The primary outcome was a new fall within 6 months after the index visit. Survival and logistic regression analyses were conducted. Results: The cohort included 1241 patients (median age 80 years (IQR 73–85), 69.1% female). The algorithm allowed the classification of 1039 patients (88.7%) as high risk, 39 (3.3%) as intermediate risk and 93 (7.9%) as low risk of future falls. Overall, there were 134 patients (11.4%) who met the outcome and experienced a new fall within 6 months after the index ED visit. The cumulative probability of suffering a new fall was 13% (95% CI 10.8% to 15.1%), 17% (95% CI 4.8% to 29.1%) and 8.5% (95% CI 2.4% to 14.6%) in the high-risk, intermediate-risk and low-risk groups, respectively, without significant differences between groups (log-rank=0.422). Being classified as high risk had a sensitivity of 90% (95% CI 85% to 95%) and a specificity of 11% (95% CI 10% to 13%) for new falls. Conclusions: A new fall-risk screening tool, based on the WFG algorithm, had poor discriminatory capacity in our ED cohort to predict new falls within 6 months of the index fall.
- 18 March 2026
- Published by BMJ in Emergency Medicine Journal
Fall risk prediction in older adults at the emergency department: where the guidelines do not fit
Background: Falls represent 10% of emergency department (ED) visits in older patients. Identification of those at risk for future falls is important to allow for preventive interventions. The aim of the study was to investigate the accuracy of a new algorithm, based on an adaptation of the World Falls Guidelines (WFG) for falls prevention and management, to identify patients at high risk of recurrent falls in a cohort of older patients with fall-related visits to the ED. Methods: The FALL-ER registry is a prospective, observational, multipurpose cohort including consecutive, community-dwelling patients age ≥65 years, attending the ED of five Spanish hospitals after a fall during 52 randomly selected days between 2014 and 2015. Variables necessary to operationalise the algorithm or a proxy when necessary were recorded. The primary outcome was a new fall within 6 months after the index visit. Survival and logistic regression analyses were conducted. Results: The cohort included 1241 patients (median age 80 years (IQR 73–85), 69.1% female). The algorithm allowed the classification of 1039 patients (88.7%) as high risk, 39 (3.3%) as intermediate risk and 93 (7.9%) as low risk of future falls. Overall, there were 134 patients (11.4%) who met the outcome and experienced a new fall within 6 months after the index ED visit. The cumulative probability of suffering a new fall was 13% (95% CI 10.8% to 15.1%), 17% (95% CI 4.8% to 29.1%) and 8.5% (95% CI 2.4% to 14.6%) in the high-risk, intermediate-risk and low-risk groups, respectively, without significant differences between groups (log-rank=0.422). Being classified as high risk had a sensitivity of 90% (95% CI 85% to 95%) and a specificity of 11% (95% CI 10% to 13%) for new falls. Conclusions: A new fall-risk screening tool, based on the WFG algorithm, had poor discriminatory capacity in our ED cohort to predict new falls within 6 months of the index fall.
- 10 February 2026
- Published by Elsevier in Revista Clínica Española (English Edition)
- Vol. 226 (3) , 502484
Reply to: Start of sodium-glucose cotransporter type 2 inhibitors (iSGLT2) in patients with acute heart failure in the Emergency room?
- 10 February 2026
- Published by Elsevier in Revista Clínica Española (English Edition)
- Vol. 226 (3) , 502484
Reply to: Start of sodium-glucose cotransporter type 2 inhibitors (iSGLT2) in patients with acute heart failure in the Emergency room?
- 5 May 2025
- Published by Springer Nature in Internal and Emergency Medicine
- Vol. 21 (1) , 231-241
Carbohydrate antigen 125 determined on arrival at the emergency department correlates with severity of decompensation and adverse outcomes in patients with acute heart failure
To investigate the capacity of carbohydrate antigen 125 (CA125) to detect severe decompensation in patients diagnosed with acute heart failure (AHF) in the emergency department (ED) and to predict 1-year mortality. We assessed CA125 at ED arrival in unselected patients diagnosed with AHF in five Spanish hospitals during November–December 2022. CA125 was categorized as tertiles. As markers of severity of decompensation, we assessed MEESSI-AHF score, need for hospitalization, prolonged hospitalization (> 7 days), and in-hospital mortality, while 30-day post-discharge adverse events (ED revisit, hospitalization, or death) and 1-year all-cause mortality were considered as outcomes. Unadjusted and adjusted comparisons among CA125 tertile categories and severity of decompensation and outcomes were performed using logistic and Cox regression. The relationship between CA125 along its continuum and 1-year mortality was also assessed by restricted cubic spline (RCS) curves. We included 429 patients. The median age was 83 years, 57% were female, and the median CA125 was 37 U/mL (IQR: 16–78). After adjustment by age, sex, dementia, sodium, and NT-proBNP, the need for hospitalization was higher in those in the upper tertile (> 55.8 U/ml) vs the lowest tertile (< 22.4 U/ml) of CA125 (OR = 1.996, 95% CI 1.092–3.647). Similarly, under the same multivariate setting, the upper CA125 tertile was associated with higher 1-year mortality (OR = 2.271, 95%CI 1.272–4.052). The RCS model showed that 1-year mortality steadily increased until 100 U/ml. At higher values, there was a softer increase. CA125 determined on arrival at the ED in patients with AHF could help to determine the severity of decompensation and is associated with a higher risk of death during the following year after decompensation.
- 5 May 2025
- Published by Springer Nature in Internal and Emergency Medicine
- Vol. 21 (1) , 231-241
Carbohydrate antigen 125 determined on arrival at the emergency department correlates with severity of decompensation and adverse outcomes in patients with acute heart failure
To investigate the capacity of carbohydrate antigen 125 (CA125) to detect severe decompensation in patients diagnosed with acute heart failure (AHF) in the emergency department (ED) and to predict 1-year mortality. We assessed CA125 at ED arrival in unselected patients diagnosed with AHF in five Spanish hospitals during November–December 2022. CA125 was categorized as tertiles. As markers of severity of decompensation, we assessed MEESSI-AHF score, need for hospitalization, prolonged hospitalization (> 7 days), and in-hospital mortality, while 30-day post-discharge adverse events (ED revisit, hospitalization, or death) and 1-year all-cause mortality were considered as outcomes. Unadjusted and adjusted comparisons among CA125 tertile categories and severity of decompensation and outcomes were performed using logistic and Cox regression. The relationship between CA125 along its continuum and 1-year mortality was also assessed by restricted cubic spline (RCS) curves. We included 429 patients. The median age was 83 years, 57% were female, and the median CA125 was 37 U/mL (IQR: 16–78). After adjustment by age, sex, dementia, sodium, and NT-proBNP, the need for hospitalization was higher in those in the upper tertile (> 55.8 U/ml) vs the lowest tertile (< 22.4 U/ml) of CA125 (OR = 1.996, 95% CI 1.092–3.647). Similarly, under the same multivariate setting, the upper CA125 tertile was associated with higher 1-year mortality (OR = 2.271, 95%CI 1.272–4.052). The RCS model showed that 1-year mortality steadily increased until 100 U/ml. At higher values, there was a softer increase. CA125 determined on arrival at the ED in patients with AHF could help to determine the severity of decompensation and is associated with a higher risk of death during the following year after decompensation.